ViroMed to conduct VM202-PAD Phase 2 clinical trial in China

Published: 2009-12-29 06:58:00
Updated: 2009-12-29 06:58:00
VM202 Phase 2 clinical trials for Peripheral Artery Disease (PAD) will commence in China, projected to be the third largest pharmaceutical market in the world by 2013.

Unlike other treatments, VM202-PAD is designed to treat the fundamental causes of PAD. It represents a huge unmet need, as mil...

Fees

- Email service daily and homepage access.
  1. $300 per month. ($3,240 per year)
  2. 5 Email holders per each company.
  3. Anual contract base.



Most Read News


TOP
BACK
Address: 295-1, Chungpa-Ro, Yongsan-Gu, Korea
Phone: 02-3270-0114 | Fax: 02-3270-0129 | Email: eyd@yakup.com

Copyright © Yakup Shinmoon, Inc. All Rights Reserved.